Protein L-isoaspartyl methyltransferase (Pimt) is a highly conserved enzyme
utilising S-adenosylmethionine (AdoMet) to methylate aspartate residues of
proteins damaged by age-related isomerisation and deamidation. We have bee
n particularly interested in this enzyme since addition of the compound CGP
3466 to primary rat astroglia cell cultures resulted in an upregulation of
Pimt at the mRNA level, as shown here by semi-quantitative RT-PCR. CGP3466
is a compound related to the anti-Parkinson's drug R-(-)-deprenyl, which ha
s been shown to protect from neural apoptosis induced by trophic factor wit
hdrawal [Tatton et al., 1994. J. Neurochem, 63, 1572]. The pro-apoptotic ge
ne Bar is required in the cascade of events following withdrawal [Deckwerth
et al., 1996. Neuron 17, 401]. We therefore investigated whether Pimt over
expression was able to affect Bar-induced apoptosis in primary mouse cortic
al neurons. Our results show that Pimt is indeed able to protect from Bar-i
nduced apoptosis. Furthermore, this activity is not restricted to brain-spe
cific cell types, since the same effect is also demonstrated in COS1 cells.
In addition, mutational analysis suggests that the protective effect is de
pendent on the adenosine methionine-binding motif, which is well conserved
in protein methyltransferases, and that a mutation destroying this motif cr
ucially affects cytoskeletal structures of the cell. (C) 1999 Elsevier Scie
nce B.V. All rights reserved.